DENTSPLY Sirona Inc [XRAY] stock is trading at $17.87, up 3.00%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The XRAY shares have gain 3.53% over the last week, with a monthly amount drifted -27.48%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
DENTSPLY Sirona Inc [NASDAQ: XRAY] stock has seen the most recent analyst activity on November 07, 2024, when Leerink Partners downgraded its rating to a Market Perform. Previously, Needham reaffirmed its Buy rating on October 25, 2024, and dropped its price target to $29. On August 20, 2024, Needham reiterated its Buy rating but maintained its price target of $34 on the stock. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $42 on February 26, 2024. Needham initiated its recommendation with a Buy and recommended $35 as its price target on November 16, 2023. William Blair upgraded its rating to Outperform for this stock on November 10, 2023. In a note dated January 12, 2023, William Blair upgraded an Mkt Perform rating on this stock.
DENTSPLY Sirona Inc [XRAY] stock has fluctuated between $17.21 and $37.60 over the past year. Currently, Wall Street analysts expect the stock to reach $40 within the next 12 months. DENTSPLY Sirona Inc [NASDAQ: XRAY] shares were valued at $17.87 at the most recent close of the market. An investor can expect a potential return of 123.84% based on the average XRAY price forecast.
Analyzing the XRAY fundamentals
DENTSPLY Sirona Inc [NASDAQ:XRAY] reported sales of 3.90B for the trailing twelve months, which represents a growth of 0.42%. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.14 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.93.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.70 points at the first support level, and at 17.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.05, and for the 2nd resistance point, it is at 18.23.
Ratios To Look Out For
For context, DENTSPLY Sirona Inc’s Current Ratio is 1.25. As well, the Quick Ratio is 0.84, while the Cash Ratio is 0.19. Considering the valuation of this stock, the price to sales ratio is 0.91, the price to book ratio is 1.43.
Transactions by insiders
Recent insider trading involved Campion Simon D, President, CEO & Member of BOD, that happened on Nov 12 ’24 when 11306.0 shares were purchased. Director, LUCIER GREGORY T completed a deal on Aug 08 ’24 to buy 8212.0 shares. Meanwhile, Director LUCIER GREGORY T bought 3577.0 shares on May 31 ’24.
